Radiotherapy & Oncology
Volume 94, Issue 2 , Pages 168-172, February 2010

The use of probability maps to deal with the uncertainties in prostate cancer delineation

University Medical Center Utrecht, Department of Radiotherapy, The Netherlands

Received 19 October 2009; received in revised form 9 December 2009; accepted 20 December 2009. published online 20 January 2010.

Abstract 

Background and purpose

The use of dynamic contrast-enhanced (DCE) imaging for delineation of prostate tumors requires that decisions are made on a voxel wise basis about the presence of tumor. While the sensitivity and specificity of this technique is high, we propose a probabilistic approach to deal with the intrinsic imaging uncertainty.

Material and methods

Twenty-nine patients with biopsy-proven prostate cancer underwent a DCE-CT exam prior to radiotherapy. From a logistic regression on Ktrans values from healthy and diseased appearing prostate regions we obtained a probability function for the presence of tumor. Ktrans parameter maps were converted into probability maps and a stratification was applied at the 5% and 95% probability level, to identify low-, intermediate-, and high-risk areas for the presence of tumor.

Results

In all patients, regions with high-, intermediate-, and low-risk were identified, with median volume percentages of 7.6%, 40.0%, and 52.1%, respectively. The contiguous areas that resulted from the voxel wise stratification can be interpreted as GTV, high-risk CTV, and CTV.

Conclusions

Ktrans parameter maps from a DCE-CT exam can be converted into probability maps for the presence of tumor. In this way, the intrinsic uncertainty that a voxel contains tumor can be incorporated into the treatment planning process.

Keywords: Prostate cancer, Tumor delineation, Dynamic contrast-enhanced (DCE) imaging, Probability maps

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0167-8140(09)00681-1

doi:10.1016/j.radonc.2009.12.023

Radiotherapy & Oncology
Volume 94, Issue 2 , Pages 168-172, February 2010